Modern Radiopharmaceuticals for lung cancer imaging with positron emission tomography/ computed tomography scan: A systematic review
- Δημιουργηθηκε στις Δευτέρα, 28 Δεκεμβρίου 2020 10:22
“Modern Radiopharmaceuticals for lung cancer imaging with positron emission tomography/ computed tomography scan: A systematic review” by Athanasios Theodoropoulos, Ioannis Gkiozos, Georgios Kontopyrgias et all, in SAGE Open Med. 2020, September28;8.
Lung cancer is one of the world’s most common and aggressive neoplasms. For this reason, it is important to have a timely diagnosis and then a proper treatment and follow-up. Positron emission tomography/computed tomography (PET/CT) is a useful tool for detecting, staging, taking therapeutic decisions, and assessing response to treatment (chemotherapy, radiotherapy, immunotherapy, etc.).